ClinicalTrials.gg
RecruitingNCT06176924Updated Dec 20, 2023

Effect of tDCS Along With Relaxation Technique on Anxiety Level in Students Preparing for Competitive Exams

An interventional study of tDCS and Relaxation technique in Anxiety, sponsored by Maharishi Markendeswar University (Deemed to be University). Recruiting at 1 site in India. Open to participants aged 15 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-20.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Maharishi Markendeswar University (Deemed to be University) · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2024, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Aug 2023, registered Dec 2023).
  • Started Aug 2023; still recruiting 3 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
15 Years to 18 Years
Sex
All
01

Study summary

Anxiety is one of the most significant obstacles to academic success. When stress is interpreted negatively or becomes overwhelming, it causes anxiety before and during examinations, which in turn impacts students' academic performance. The difficulty in managing severely associated anxiousness enhances the demand for NIBS. It is a unique approach that has the potential to alleviate anxiety by modifying cortical excitability whereas Relaxation breaks the vicious cycle of pain caused by muscular stress, circulatory illness, and metabolic by-products alterations. The main purpose is to evaluate whether tDCS along with Relaxation technique reduces the anxiety level in competitive exam students. Total 46 students are recruited and randomly allocating in experimental and control group. The subjects in the experimental group are going to receive 9 tDCS sessions (2mA, anode placed on the DLFPC of left side and cathode on right supraorbital cortex for 20 min) along with relaxation technique. Subjects in the control group are going to receive 9 sessions of relaxation. The CSAI-2R scale is used as an Outcome Measure. Samples completed the CSAI-2R scale before and following the intervention. The data will be analyzed using SPSS 26.0 software.

02

Conditions studied

  • Anxiety

Browse trials for

Keywords

  • Anxiety, tDCS, Relaxation, Competitive Exam Students, 2mA, CSAI-2R
03

In context

Anxiety Disorders Unverified

7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's planned enrollment of 46 is below the median of 80 across 6,057 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Maharishi Markendeswar University (Deemed to be University) is the lead sponsor of 41 studies on the registry; 4 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
15 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: • Both male and female students.

  • Competitive Exam students only.
  • Age group between 15 years to 18 years.
  • Willingness to take part in the research.

Exclusion Criteria: • Seizure disorder

  • Non-Corporative students
  • Skin irritation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Active tDCS and Relaxation technique

    Subjects within an experimental group had received 9 sessions of tDCS (2mA, 20 min anode placed on DLFPC of left side and cathode on supraorbital cortex of right side) along with relaxation technique.

    Device: tDCS · Other: Relaxation technique

  • Other
    Relaxation technique

    Subjects in the control group are going to receive 9 sessions of relaxation technique

    Other: Relaxation technique

Interventions

  • DevicetDCS

    tDCS (2mA, 20 min anode placed on DLFPC of left side and cathode on supraorbital cortex of right side) along with relaxation technique.

  • OtherRelaxation technique

    Relaxation technique

06

What researchers measure

Primary outcomes

  1. CSAI- 2R (Competitive State Anxiety Inventory-2R)

    It is a reliable and viable scale for assessing the level of competitive anxiety. It's having 27 components, each having 4 grades ranging from 1 to 4.

    Time frame: 5 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 20, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06176924
Lead sponsor
Maharishi Markendeswar University (Deemed to be University)
Responsible party
Subhasish Chatterjee (Effect of tDCS along with relaxation technique on anxiety level in students preparing for competitive exams: A Randomized Controlled Trial, Maharishi Markendeswar University (Deemed to be University)) — Principal investigator
First posted
Dec 20, 2023
Start date
Aug 1, 2023
Primary completion
Jan 10, 2024 (estimated)
Completion
Feb 10, 2024 (estimated)
Last update
Dec 20, 2023

Study contacts

Rama Taneja
Contact
ramataneja.055@gmail.com
09518260372

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion